Similar documents
I II III 28 29

生活設計レジメ

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)


i


Wide Scanner TWAIN Source ユーザーズガイド

橡NO005-PDF用.ec5

untitled

福祉行財政と福祉計画[第3版]

橡ミュラー列伝Ⅰ.PDF

II III I ~ 2 ~

中堅中小企業向け秘密保持マニュアル

- 2 -


第124回日本医学会シンポジウム

1 (1) (2)

provider_020524_2.PDF

「産業上利用することができる発明」の審査の運用指針(案)


178 5 I 1 ( ) ( ) ( ) ( ) (1) ( 2 )

untitled

CRS4

ii

untitled

i

AccessflÌfl—−ÇŠš1

2





ito.dvi

入門ガイド

SC-85X2取説


C H N

<4D F736F F F696E74202D C835B B E B8CDD8AB B83685D>

表紙07 [更新済み]



(個別のテーマ) 医療処置に関連した医療事故

(個別のテーマ) 薬剤に関連した医療事故

(個別のテーマ) 医療機器の使用に関連した医療事故

(個別のテーマ) 放射線検査に関連した医療事故

.V...z.\

201604_建築総合_2_架橋ポリ-ポリブテン_cs6.indd




II

これわかWord2010_第1部_ indd

パワポカバー入稿用.indd

これでわかるAccess2010

ÿþ

p0124_03

計算機生命科学の基礎II_

untitled

橡01固定資産税に係る主な論点.PDF

untitled

untitled

広報えちぜん12月号_4校.indd

14:10~14:20 14:20~14:50 14:50~15:40 15:40~16:00 16:00~16:10



report_c.ai

Transcription:

-1 -

-2 -

-3 -

-4 -

-5 -

-6 -

-7 -

-8 -

-9 -

- 10 -

-11 -

- 12 -

- 13 -

- 14 -

- 15 -

- 16 -

- 17 -

- 18 -

- 19 -

- 20 -

- 21 -

- 22 -

- 23 -

- 24 -

- 25 -

- 26 -

- 27 -

- 28 -

- 29 -

- 30 -

- 31 -

- 32 -

- 33 -

- 34 -

- 35 -

- 36 -

- 37 -

- 38 -

- 39 -

- 40 -

- 41 -

- 42 -

- 43 -

17 RI 16 H16.3 H12.10 H8.4 S54.4 H15.4 H12.4 H17.5 H12.12 H16.9 H17.4 H17.4 H17.5 H17.10 H18.2 DNA PCRDNA MALDI-TOF/TOF 50 300-44 -

DNA - 45 -

http:/www.gifu-u.ac.jp/~lsrc 2 (2005 ) - 46 -

- 47 -

- 48 -

- 49 -

- 50 -

- 51 -

- 52 -

- 53 -

2005 4 21 17 RI 2005 6 4 2 2005 7 22 4 Jr. 19 15 2005 8 10-54 -

2005 12 15 5-55 -

- 56 -

; 600 ; DNA Zeiss Beckman Beckman TOMY Beckman BIORAD GenePulser CCD Zeiss CCD Zeiss Zeiss Lumat BIORAD PDS-1000DNA ABI373AABI310ABI3100 Procise clc GE Typhoon Affimetrix Becton DickinsonHPLC 290 146 95 28 5 16 67 56 2 2 1 6-57 -

1 FACS FACS 1FACS Calibur 2 3 2RI RI 16-58 -

- 59 -

1. 2. - 60 -

- 61 -

- 62 -

- 63 -

- 64 -

- 65 -

- 66 -

- 67 -

- 68 -

- 69 -

- 70 -

- 71 -

- 72 -

- 73 -

RI RI - 74 -

RNA in vitro RNA I sirna CYP3A H The Replication Fork Protection Complex Drexel University College of Medicine H H H Vibrio furnissii Vibrio cholerae Rochester - 75 -

Gateway DNA l ND1000 Miniscope TM1000 DNA BZ8000 ZOOM IPG SSH 17 17-76 -

DNA 1 I - 77 -

DNA 1,753 m 2 RI RI P1 P2 P3 DNA 233 DNA RI 123 17 4 21 178 17 5 20 MRC DNA Dr. David Loakes (MRC, Laboratory of Molecular Biology, Cambridge, UK) - 78 -

DNA 17 7 10 DNA DNA SSP 40 in vitro DNA II III MATE DNA - 79 -

15 4 4 5 5 12 16 10 15 RI 16 14 DNA 15 DNA 2 DNA DNA 22 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. - 80 -

13. 14. 15. 16. 17. 18. 19. 20. 21. CCD 18 3 31 13 57 3 1 1 49 38 2 ( )15 50 230 86 425 519 830 831 922 111 123 ( ) - 81 -

GeneChip technology 20 12 16 ( ) DNA DNA 1. 2. 3.PCR 4.RNA 5.RT-PCR 6. 7.DNA 14 7 7 81 8 5 ( ) (1) (2) DNA (3) DNA (1) (2) DNA (3) - 82 -

6 13 73031 ( ) D Jr. 1 2 DNA 3RFLP 4PCR 5 DNA 6RT-PCR 7 25 1223 12 25 ( ) 17 4 26 5 10 17 6 27-83 -

DNA 527 4568 1568 3030-84 -

- 85 -

Hara, K., Okamoto, M., Aki, T., Yagita, H., Tanaka, H., Mizukami, Y., Nakamura, H., Tomoda, A., Hamasaki, N., Kang, D., Synergistic enhancement of TRIL- and tumor necrosis factor a-induced cell death by a phenoxazine derivative, Mol. Cancer Ther.4 (7), 1121-1127 (2005) Aki, T., and Mizukami, Y., Regulation of Cardiomyocyte functions by distinct phosphoinositide 3-kinase, Molecular Mechanisms of Heart diseases, (Edits Mizukami, Y. and Ohkusa, T.) Publisher Research Signport, 85-99 (2005) Kimura, Y, and Mizukami, Y.,and Matsuzaki, M., Orphan G protein-coupled receptor and ischemia, Molecular Mechanisms of Heart diseases, (Edits Mizukami, Y. and Ohkusa, T.) Publisher Research Signport, 99-113 (2005) - 86 -

- 87 -

- 88 -

- 89 -

- 90 -

- 91 -

- 92 -

- 93 -

RI DNA P2 P3 DNA DNA DNA DNA C TOF-MS 3130 Avant - 94 -

in DNA type III - 95 -

- 96 -

- 97 -

- 98 -

- 99 -

- 100 -

- 101 -

- 102 -

- 103 -

IV100-104 -

- 105 -

- 106 -

- 107 -

- 108 -

- 109 -

- 110 -

17 4 2 3 FSRC 2 ( ) 30 30 RNA P3 DNA 4 1 RI -80 CCD TOF PCR [450 ] 17 17 13 1 1/4 6 5 17 2 4 1 30 3-111 -

DNA 17 1 1 17 3 30 DNA 4648 250 /1 758 1000 /1 370 PCR46 TOF 925 26 DNA 101 20 88 345 2 2 L5 FL 3 20 3 24 () 8 4 DNA 8 6 30 11 6 4 8 9 2 4 (3 ) (9 ) 2 17 9 11 19 12 17 11 6-112 -

500-113 -

- 114 -

68 1 6 15 36 1 4 130-115 -

- 116 -

- 117 -